USPTO Director’s Growing Influence on Post-Grant Review Proceedings: Implications for Legal Professionals

In the latest episode of Troutman Pepperโ€™s Intellectual Property and Health Sciences practice groups’ podcast series, the focus is on the US Patent Office (USPTO) and the conspicuous role the USPTO director has been assuming in inter partes and post-grant review proceedings. The meta description of the podcast indicates the presence of significant events and…

Read More

Crucial Patent Term Adjustment Case Sheds Light on Obviousness-Type Double Patenting Issues

In the unfolding legal saga, In Re: Cellect, LLC No. 2022-1293 (Fed. Cir. Aug. 28, 2023), a crucial case illuminates an area of Patent Term Adjustment (PTA) and its interaction with the interesting issue of obviousness-type double patenting (ODP). This case has become critical for corporations and legal professionals specializing in Intellectual Property (IP). According…

Read More

Federal Circuit Explores Indefiniteness in Inter Partes Reviews: Navigating Means-Plus-Function Claim Elements

The Federal Circuit has been delving deeper into the realm of indefiniteness in Inter Partes Reviews (IPRs). A particular focus is on means-plus-function claim elements which present a complicated issue in an IPR as they are claim elements drafted under 35 U.S.C. ยงย 112(f) (or its predecessor paragraph 6), expressing an element of a combination as…

Read More

Fraudulent Declarations in Trademark Law: Federal Circuit Limits TTAB’s Authority to Cancel Registrations

For nearly half a century, the Trademark Trial and Appeal Board (TTAB) of the U.S. Patent & Trademark Office exercised authority that when a trademark registrant files a fraudulent declaration under Section 15 of the Lanham Act, in an effort to make its registration incontestable, that registration would be immediately cancelled in its entirety. This…

Read More

NetDocuments Launches AI-Powered PatternBuilder MAX with Nine Apps for Common Legal Use Cases

In July, NetDocuments commenced a trial launch of its AI-based product, PatternBuilder MAX. This generative AI tool aspires to facilitate firms in creating customized AI automation that caters to their specific practice areas, offering a glimpse into the transformative potential of AI in streamlining operations for legal firms. This product was intended as the forebear…

Read More

Maine Judge Upholds Patent Infringement Suit: Implications for Future Electromagnetic Technology Cases

In a recent legal update, a federal judge in Maine rejected a motion to dismiss a patent infringement suit against Rejuva Fresh and its owner, Polly Jacobs. The case, initiated by BTL Industries Inc., concerns the allegedly unauthorised use of electromagnetic technology in noninvasive aesthetic body-contouring devices. The court found that a letter sent by…

Read More

UPC Court of Appeal’s Landmark Ruling Clarifies Procedural Timelines and Annex Requirements

The United Patent Court (UPC) Court of Appeal on 16th October 2023 declared their first-ever decision, addressing two noteworthy procedural issues that arise when a Statement of Claim is executed without the referred documents, or “annexes”. This landmark decision was announced by global law firm Allen & Overy LLP. The UPC Court of Appeal’s decision…

Read More

Calculating Damages in Two-Product Markets: Bamboo Decking Case Sheds Light on Patent Infringement Consequences

In a notable legal dispute in the District of Delaware, a ruling was made that validated a jury award based on lost profits in a two-product market for bamboo decking. This case underscores the potential nuances of calculating damages in markets consisting of merely a few players. In the absence of non-infringing alternatives, evidence may…

Read More

Bristol-Myers Squibb and Nanocopoeia Face Off in Pivotal Pharmaceutical Patent Dispute

The legal battle between Bristol-Myers Squibb Co. and Nanocopoeia, LLC continues to garner industry attention. The case is formally known as Bristol-Myers Squibb Co. v. Nanocopoeia, LLC, No. 22-cv-1283, 2023 WL 2867945 (D. Minn. Apr. 10, 2023) (Menendez, J.). This dispute involves the drug product Sprycel® (dasatinib) and two relevant U.S. patents – Nos. 7,491,725…

Read More

San Francisco to Host Event Exploring Patent Complexities in Blockchain and Distributed Ledger Technologies

The significance of blockchain and distributed ledger technologies (DLTs) continues to ascend, proving their use and application in various fields, beyond just cryptocurrencies and financial markets. However, with this steady dawn of adoption and application, there is an emerging hotbed of patent disputes and intellectual property rights complexities. To delve into these issues, the city…

Read More

Federal Circuit Limits TTAB Authority in Reversal of Trademark Cancellation Decision

In a recent development, a divided panel of the Federal Circuit issued a precedential decision, reversing the United States Patent and Trademark Office’s (USPTO) cancellation of a registered trademark (Great Concepts, LLC v. Chutter, Inc., No. 2022-1212). Details of this case have revealed a pivotal judgement concerning the power of the Trademark Trial and Appeal…

Read More

AI-Assisted Patent Prosecution: Navigating Benefits and Ethical Considerations

In the complex legal terrain where patent prosecution thrives, artificial intelligence (AI) offers increasingly valuable tools for practitioners. AI language models, known as large language models (LLMs), generate human-like text responses to user prompts using intricate deep learning algorithms. Initially, the use of LLMs within patent prosecution was cloaked in skepticism around issues of accuracy,…

Read More